Application of anti-TNF drugs to disrupt the costimulatory interaction between mTNF on CD14+ macrophages and tumor necrosis factor receptor 2 (TNFR2) on T cells from the mucosa of patients with IBD has been shown to induce T cell apoptosis (133). Here, TNFRSF1B is linked to inflammatory bowel disease.